Literature DB >> 290378

The structure of depression in heroin addicts.

B F Shaw, R A Steer, A T Beck, J Schut.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 290378     DOI： 10.1111/j.1360-0443.1979.tb01351.x

Source DB:  PubMed          Journal:  Br J Addict Alcohol Other Drugs        ISSN： 0007-0890


× No keyword cloud information.
  6 in total

1.  Substance abuse and psychopathology. A diagnostic screening of Italian narcotic addicts.

Authors:  M Clerici; I Carta; C L Cazzullo
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1989-07       Impact factor: 4.328

2.  The association between naltrexone treatment and symptoms of depression in opioid-dependent patients.

Authors:  David J Mysels; Wendy Y Cheng; Edward V Nunes; Maria A Sullivan
Journal:  Am J Drug Alcohol Abuse       Date:  2010-12-30       Impact factor: 3.829

3.  Demographic influences and suggested cut-scores for the Beck Depression Inventory in a non-clinical Spanish speaking population from the US-Mexico border region.

Authors:  S E Dawes; P Suarez; F Vaida; T D Marcotte; J H Atkinson; I Grant; R Heaton; M Cherner
Journal:  Int J Cult Ment Health       Date:  2010

4.  Screening for depressive symptoms among HCV-infected injection drug users: examination of the utility of the CES-D and the Beck Depression Inventory.

Authors:  Elizabeth T Golub; Mary Latka; Holly Hagan; Jennifer R Havens; Sharon M Hudson; Farzana Kapadia; Jennifer V Campbell; Richard S Garfein; David L Thomas; Steffanie A Strathdee
Journal:  J Urban Health       Date:  2004-06       Impact factor: 3.671

Review 5.  What we have learned from the Methadone Maintenance Treatment of Dual Disorder Heroin Use Disorder patients.

Authors:  Angelo G I Maremmani; Matteo Pacini; Icro Maremmani
Journal:  Int J Environ Res Public Health       Date:  2019-02-03       Impact factor: 3.390

6.  Diffusivity of the uncinate fasciculus in heroin users relates to their levels of anxiety.

Authors:  N M L Wong; S-H Cheung; C C H Chan; H Zeng; Y-P Liu; K-F So; T M C Lee
Journal:  Transl Psychiatry       Date:  2015-04-28       Impact factor: 6.222
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.